Best U.S. Cannabis Stocks to Buy Now as Legalization Efforts Advance
The U.S. cannabis market continues to show strong growth, with sales reaching approximately $38.5 billion in 2024. Analysts expect this figure to exceed $44 billion in 2025. The industry supports over 440,000 full-time jobs and remains one of the fastest-growing sectors in the country. Demand continues rising in both medical and adult-use markets, especially in newly legalized states. This week, several marijuana stocks are showing strength, especially companies with strong U.S. footprints and improving financials. Names like AYR Wellness, Ascend Wellness, and Glass House Brands are gaining investor attention. Their operations span high-growth states with favorable cannabis laws. However, due to sector volatility, using technical analysis is key. Traders are watching support levels, trendlines, and breakouts to time entries. Additionally, risk management must be a top priority. Limiting position sizes and setting tight stop-loss levels help protect capital while allowing for upside exposure.
Recent headlines continue to influence marijuana stocks. Calls for federal legalization and reclassification of cannabis have gained renewed traction. Politicians and advocacy groups are pushing for reform that includes safer banking access and lighter penalties. Several states are actively considering new adult-use legislation this year. These developments help drive momentum and create optimism for long-term growth.
U.S. Cannabis Market Volatility and Growth
However, the market remains news-sensitive, and sudden shifts can impact stock prices quickly. Therefore, short-term traders should rely on chart analysis. Watch for volume spikes, resistance breakouts, and key moving averages. Long-term investors should look for improving fundamentals and reduced debt levels. Meanwhile, proper risk controls remain essential. Avoid overexposure to single names and maintain a balanced portfolio. In a sector full of potential but marked by uncertainty, discipline and strategy make all the difference. This week’s watchlist offers opportunities, but success depends on preparation and smart execution.
As the U.S. cannabis market continues to expand, investors are turning their attention to top-performing marijuana stocks with strong fundamentals and growth potential. With the cannabis industry projected to surpass $40 billion in annual sales by 2025, identifying companies with multi-state footprints, improving financials, and clear strategic visions is critical. This July, three cannabis operators stand out: AYR Wellness Inc. (AYRWF), Ascend Wellness Holdings, Inc. (AAWH), and Glass House Brands Inc. (GLASF). Each company offers a distinct path to profitability and holds a competitive position in its regional market. Here’s a closer look at these top marijuana stocks to watch in July 2025.
[Read More] 3 Marijuana Stocks To Build A Strong Portfolio
Best Pot Stocks to Buy Now: July 2025 Cannabis Watchlist
- AYR Wellness Inc. (OTC: AYRWF)
- Ascend Wellness Holdings, Inc. (OTC: AAWH)
- Glass House Brands Inc. (OTC: GLASF)
AYR Wellness Inc. (AYRWF)
AYR Wellness Inc. is a vertically integrated cannabis company with operations in several high-growth U.S. markets. Headquartered in Florida, AYR operates more than 90 dispensaries nationwide, with its largest footprint concentrated in Florida, where it runs over 60 stores. The company also has a retail and cultivation presence in states like Pennsylvania, Massachusetts, New Jersey, Illinois, and Nevada. Through vertical integration, AYR controls its supply chain from cultivation to retail. This allows it to manage costs, protect margins, and maintain product consistency. Its branded products, including Levia, Kynd, and HAZE, are well-known in competitive adult-use and medical markets. The company has steadily increased brand recognition and customer loyalty, particularly in Florida, a key medical cannabis market. With adult-use legalization potentially on the horizon in several states, AYR is positioned to benefit from favorable legislative shifts.
In its most recent earnings report for Q1 2025, AYR reported revenue of $118.3 million. This figure was slightly lower than the previous quarter but remained in line with expectations. Adjusted EBITDA reached $27.8 million, reflecting the company’s continued focus on operational efficiency. Gross margin remained solid at 45%, aided by disciplined cost control. While the company posted a net loss of $9.5 million, this represented an improvement compared to previous quarters. Additionally, AYR generated $5.4 million in positive cash flow from operations—a notable milestone. Capital expenditures were scaled back to preserve liquidity, and the company continued to focus on high-return projects. Management emphasized its commitment to profitable growth and improving margin expansion throughout 2025. With a strong retail base, improving cash flow, and expansion into new adult-use markets, AYRWF is well-positioned for long-term success.
[Read More] Marijuana Market Watch: Stocks to Track as the Industry Expands in 2025
Ascend Wellness Holdings, Inc. (AAWH)
Ascend Wellness Holdings, Inc. is another rising cannabis operator making waves across the U.S. As a vertically integrated multi-state operator (MSO), Ascend currently operates in seven states: Illinois, Michigan, Massachusetts, Ohio, New Jersey, Pennsylvania, and Maryland. Its largest presence is in Illinois, where it holds a significant share of the retail and wholesale markets. The company operates 37 dispensaries as of mid-2025, with more openings planned later this year. Ascend focuses on establishing retail locations in densely populated areas and pairing them with strong cultivation and processing facilities. It owns several in-house brands, including SimplyHerb and Ozone, which are sold across its retail footprint and via wholesale channels. Ascend’s strategy centers on capturing market share in states transitioning from medical to adult-use, where demand often outpaces supply.
Financially, Ascend continues to show steady progress. In Q1 2025, the company reported revenue of $120.2 million, up 4% from the previous quarter. Adjusted EBITDA came in at $32.7 million, representing a healthy 27% margin. Notably, Ascend achieved positive operating income for the first time—a significant milestone. Gross margins improved to 49%, driven by increased cultivation efficiency and stronger pricing. Net loss narrowed to $6.1 million, a meaningful improvement from the $15 million loss reported the same period last year. Positive operating cash flow and more than $80 million in cash on the balance sheet indicate strong financial footing. The company also reduced its capital expenditures to improve free cash flow. Ascend plans to expand further in Ohio and New Jersey, two markets with promising adult-use potential. With rising profitability and a growing footprint, AAWH is becoming a serious contender among U.S. cannabis operators.
Glass House Brands Inc. (GLASF)
Glass House Brands Inc. is one of the largest and most cost-efficient cannabis cultivators in the United States. Based in California, the company operates primarily in the premium flower segment and focuses on environmentally sustainable, greenhouse-grown cannabis. Its flagship cultivation facility, located in Santa Barbara County, spans more than 5.5 million square feet, making it the largest greenhouse cannabis operation in the country. Glass House currently operates 11 dispensaries, mostly across Southern California, including the key urban markets of Los Angeles, San Diego, and Santa Barbara. Its well-known brands include Glass House Farms, FIELD, and PLUS gummies, all of which cater to both medical and adult-use consumers. The company’s low-cost cultivation model allows it to offer premium products at competitive prices, making it a dominant player in the California cannabis market.
Glass House has demonstrated significant improvement in its financials throughout 2025. In Q1, the company reported $39.2 million in revenue, a 5% increase from the prior quarter. Adjusted EBITDA came in at $4.1 million, reflecting meaningful year-over-year improvement. Gross margins rose to 32%, driven by higher yields and reduced production costs. The company reported a net loss of $3.8 million, significantly better than the $10 million loss reported in early 2024.
Positive operating cash flow was achieved for the first time, signaling a turning point in financial performance. The company also set a new cultivation record, harvesting 140,000 pounds of cannabis in the quarter. Production costs dropped to under $150 per pound, making it one of the most efficient cultivators in the U.S. With $30 million in cash on hand and a disciplined capital strategy, Glass House is focused on scaling profitably. As California stabilizes and demand grows, GLASF could emerge as a nationwide leader.
[Read More] 3 Marijuana Stocks For Investors To Make Profits
Top Pot Stocks to Watch This Week with Strong Growth Potential
The cannabis industry continues to present opportunities for growth-oriented investors in 2025. AYRWF, AAWH, and GLASF each bring a unique value proposition. AYR dominates the Florida medical market and is expanding in adult-use states. Ascend is gaining momentum in the Midwest and East with improving margins and strong operations. Glass House, meanwhile, commands California with unmatched scale and production efficiency. While the sector remains volatile, these three companies are showing the fundamentals and discipline needed to lead the next phase of cannabis growth. As U.S. legalization efforts continue and operational performance improves, these marijuana stocks are well worth watching this July.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
